AI GRAND ROUNDS

Authors: GEMINI(RESIDENT), GROK(ATTENDING), CHATGPT (EXPERT) & ANUPAM SINGH MD(Human in loop)

Department of Medicine, Santosh Medical College.

Click here for App | Agentic Grand Rounds Index

Round 1

User: A 78-year-old man was admitted with hypercalcemia and renal failure. Four months prior, he had a similar admission for dyspnea, cough, rib pain, flank pain, and one episode of hematuria. During that previous stay, examination showed basilar rales and a grade 2/6 systolic ejection murmur. Urinalysis was normal. Imaging at that time showed basilar atelectasis, mild congestive heart failure, a 1.3 cm subpleural nodule in the right middle lobe, and stable bilateral mediastinal/hilar lymphadenopathy with coarse calcifications. He improved with supportive care and was discharged with advice for follow-up imaging and cystoscopy.

Resident:

Hello, Chief Resident here.

Key findings include recurrent hypercalcemia, acute kidney injury (AKI), and a history of constitutional symptoms (rib/flank pain, hematuria). Imaging reveals stable calcified hilar lymphadenopathy and a subpleural nodule. The combination of hypercalcemia and renal failure in an elderly patient with bone pain and hematuria strongly suggests a plasma cell dyscrasia or malignancy.

Differential Diagnoses:

  1. Multiple Myeloma (45%): Explains hypercalcemia, AKI (myeloma kidney), and rib pain.
  2. Sarcoidosis (25%): Supported by bilateral hilar lymphadenopathy and hypercalcemia (1,25-dihydroxyvitamin D mediated), though calcifications suggest chronicity.
  3. Renal Cell Carcinoma (20%): Accounts for hematuria, flank pain, and paraneoplastic hypercalcemia.
  4. Hyperparathyroidism (10%): Common cause of hypercalcemia in this age group, though less likely to explain the systemic findings.

Recommended Tests:
1. Serum/Urine Protein Electrophoresis (SPEP/UPEP) with immunofixation and Free Light Chain assay: To screen for Multiple Myeloma.
2. Serum PTH and PTHrP: To differentiate between primary hyperparathyroidism and malignancy-associated hypercalcemia.
3. CT Abdomen/Pelvis: To evaluate the kidneys for masses (RCC) and assess for lytic bone lesions.
4. Serum 1,25-dihydroxyvitamin D level: To evaluate for granulomatous disease.
5. Repeat Chest CT: To characterize the subpleural nodule and lymphadenopathy.

Attending:

Hello Attending Consultant here.

Top 3 Differential Diagnoses:
1. Multiple myeloma (CRAB features: hypercalcemia, renal failure, bone pain; subpleural nodule may represent plasmacytoma).
2. Sarcoidosis (chronic calcified bilateral hilar/mediastinal LAD; 1,25-(OH)₂D-driven hypercalcemia and AKI).
3. Occult malignancy (metastatic RCC or squamous cell lung ca; explains hematuria, flank/rib pain, hypercalcemia via PTHrP).

Suggested improvements to plan (5 points):
- Order immediate SPEP/UPEP, serum free light chains, and bone marrow biopsy.
- Measure PTH, PTHrP, and 1,25-(OH)₂D to differentiate etiology.
- Perform non-contrast CT chest/abdomen/pelvis for lytic lesions, renal mass, and nodule characterization.
- Add urine calcium/creatinine ratio and 24h urine protein.
- Expedite urology cystoscopy and consider bronchoscopy with EBUS if sarcoid suspicion persists.
- Initiate aggressive IV hydration, bisphosphonate (after dental clearance), and avoid loop diuretics initially.

Limit further empiric therapy until workup clarifies diagnosis.

Expert:

Hello, Expert Clinician here.

Best unifying diagnosis: Sarcoidosis causing calcitriol-mediated hypercalcemia with AKI, likely longstanding given stable calcified bilateral hilar/mediastinal adenopathy. The lung nodule may be related but needs separate evaluation.

Top differentials:
1. Multiple myeloma — fits hypercalcemia, renal failure, rib pain; less explained by chronic calcified hilar LAD. Must exclude urgently with SPEP/UPEP, free light chains.
2. Malignancy-related hypercalcemia
- RCC fits flank pain + hematuria + hypercalcemia, but prior UA was normal and chest LAD pattern is less typical.
- Lung cancer/PTHrP possible with pulmonary nodule, but calcified symmetric hilar LAD argues more for granulomatous disease.
3. Primary hyperparathyroidism — common cause of hypercalcemia, but does not unify pulmonary findings or pain syndrome.

Key pivot: the stable, bilateral, coarsely calcified hilar/mediastinal lymphadenopathy strongly points toward chronic granulomatous disease, making sarcoid a major explanation for recurrent hypercalcemia/renal injury.

Most important next move: Immediate hypercalcemia treatment (aggressive IV saline; calcitonin if severe; consider bisphosphonate/denosumab depending on renal function) plus etiologic labs now: PTH, PTHrP, 25-OH vitamin D, 1,25-OH₂ vitamin D, SPEP/UPEP/free light chains.

Teaching pearl: In granulomatous disease, suppressed PTH with elevated 1,25-OH₂ vitamin D is the biochemical clue.

Round 2

User: Over the next four months, he experienced two more episodes of hematuria and significant fatigue, though no fevers, chills, or weight loss were reported initially. His medical history includes hypertension, hyperlipidemia, BPH, mild cognitive decline, and choreiform movements. He had undergone aortic valve replacement and aneurysm repair two years earlier. He had a positive tuberculin skin test (Mantoux) six years ago but a reportedly negative evaluation at that time. His medications included donepezil, citalopram, tamsulosin, ranitidine, quetiapine, and aspirin. On current presentation, his BP was 108/66 mmHg and pulse was 68 bpm. Examination was largely unchanged except for a grade 1/6 systolic murmur. Initial labs showed significant anemia (Hb 10.5 g/dL) and severe renal dysfunction (Creatinine 5.26 mg/dL, BUN 77 mg/dL). Calcium was markedly elevated at 14.9 mg/dL. KFT showed a sodium of 138 mmol/L and potassium of 4.9 mmol/L. LFT showed an alkaline phosphatase of 154 U/L and GGT of 152 U/L, with normal bilirubin and transaminases. His TLC was 4600/mm³ with a normal differential. ESR was elevated at 56 mm/hr.

Resident:

Hello, Chief Resident here.

The updated findings of severe hypercalcemia (14.9 mg/dL), profound AKI (Cr 5.26), and anemia, alongside a history of a positive Mantoux test and chronic calcified lymphadenopathy, shift the focus toward granulomatous disease or plasma cell dyscrasia. The choreiform movements and cognitive decline are noted but may be independent or exacerbated by metabolic derangement.

Differential Diagnoses:

  1. Sarcoidosis (40%): The stable, calcified hilar LAD and recurrent hypercalcemia/nephrocalcinosis are classic. Elevated GGT/Alk Phos suggests hepatic involvement.
  2. Multiple Myeloma (35%): Remains a top priority due to the "CRAB" features (Calcium, Renal, Anemia, Bone pain). ESR elevation is consistent.
  3. Disseminated Tuberculosis (15%): Supported by the positive Mantoux and calcified nodes, though the lack of weight loss/fever and the 4-month stability make it less likely than sarcoid.
  4. Renal Cell Carcinoma (10%): Hematuria and flank pain persist as red flags for a primary renal malignancy with paraneoplastic hypercalcemia.

Prioritized Tests:
1. Serum 1,25-dihydroxyvitamin D and PTHrP: To distinguish granulomatous activity from humoral hypercalcemia of malignancy.
2. Serum/Urine Immunofixation and Free Light Chains: To rule out Myeloma.
3. CT Chest/Abdomen/Pelvis (Non-contrast): To evaluate the subpleural nodule, renal parenchyma, and bone morphology.
4. ACE Level: Supportive (though non-specific) for sarcoidosis.
5. Renal Biopsy: If SPEP/UPEP are negative, to differentiate sarcoid interstitial nephritis from other pathologies.

Attending:

Hello Attending Consultant here.

Top 3 Differential Diagnoses:
1. Sarcoidosis (calcitriol-driven hypercalcemia, calcified bilateral hilar LAD, elevated AlkP/GGT, ESR; explains recurrent AKI, anemia of chronic disease).
2. Multiple myeloma (CRAB: Ca 14.9, Cr 5.26, Hb 10.5, bone pain; ESR 56 supportive).
3. Occult malignancy (metastatic RCC or lung ca; hematuria, flank pain, PTHrP hypercalcemia; prior positive PPD less likely active TB without fever/weight loss).

Suggested improvements (6 points):
- Order urgent PTH, PTHrP, 1,25-(OH)₂D, SPEP/UPEP, serum free light chains.
- Initiate aggressive IV saline (250–300 mL/h) + calcitonin; add zoledronate once hydrated (dose-adjust for GFR).
- Obtain non-contrast CT chest/abdomen/pelvis for lytic lesions, renal mass, nodule progression.
- Measure serum ACE; consider QuantiFERON to reassess TB risk.
- Plan renal biopsy if myeloma labs negative (interstitial nephritis vs. cast nephropathy).
- Expedite urology cystoscopy; hold ranitidine (possible interstitial nephritis contributor).
- Avoid steroids until infection/malignancy excluded.

Workup must prioritize reversible hypercalcemia while clarifying granulomatous vs. neoplastic etiology.

Expert:

Hello, Expert Clinician here.

Best current unifying diagnosis: Calcitriol-mediated hypercalcemia from granulomatous disease, most likely sarcoidosis, causing recurrent AKI. The stable, coarsely calcified bilateral hilar/mediastinal LAD is the strongest clue.

Top differentials
1. Multiple myeloma — fits hypercalcemia, renal failure, anemia, rib pain, high ESR. Does not explain chronic calcified symmetric hilar LAD well. Must be excluded urgently.
2. Renal cell carcinoma / urothelial malignancy — explains recurrent hematuria, flank pain, fatigue, and can cause hypercalcemia. Less able to unify the thoracic calcified LAD.
3. Tuberculosis or other granulomatous infection — positive prior Mantoux and calcified nodes support old granulomatous disease; active TB is less favored without fever/weight loss, but cannot dismiss.
4. Primary hyperparathyroidism — less likely with this degree of illness/AKI and does not explain chest imaging.

Key pivot: the combination of marked hypercalcemia + renal failure in a patient with chronic calcified hilar LAD points toward extrarenal 1-alpha hydroxylase activity (sarcoid/TB) unless labs prove myeloma or malignancy.

Most important next move: Treat severe hypercalcemia now (IV saline, calcitonin; antiresorptive therapy as renal function allows) and send PTH, 1,25-OH₂ vitamin D, PTHrP, SPEP/UPEP/free light chains, plus noncontrast CT abdomen/pelvis with urinary tract evaluation.

Teaching pearl: In granulomatous hypercalcemia, PTH is suppressed and 1,25-OH₂ vitamin D is elevated.

Round 3

User: During the hospital course, calcium peaked at 17.1 mg/dL. PTH was low-normal at 22 pg/mL (inappropriately non-suppressed for the level of hypercalcemia). 25-hydroxyvitamin D was low at 20 ng/mL. ACE levels were elevated at 61 U/L. Serum protein electrophoresis (SPEP) revealed an IgM kappa M-component (0.24 g/dL), and bone marrow biopsy showed 7% plasma cells with kappa light chain restriction. A skeletal survey showed diffuse osteopenia and lucent lesions in the calvarium and legs, raising suspicion for multiple myeloma or metastatic disease.

Resident:

Hello, Chief Resident here.

The case has reached a complex diagnostic intersection. We have biochemical evidence of Primary Hyperparathyroidism (inappropriately normal PTH of 22 pg/mL despite a calcium of 17.1 mg/dL) and hematologic evidence of Monoclonal Gammopathy of Undetermined Significance (MGUS) or low-burden Multiple Myeloma (7% plasma cells, IgM kappa M-protein).

Differential Diagnoses:

  1. Primary Hyperparathyroidism (45%): The non-suppressed PTH in the setting of severe hypercalcemia is definitive. This may be a parathyroid adenoma or carcinoma (given Ca >14 mg/dL).
  2. Multiple Myeloma (30%): Supported by the M-component, 7% clonal plasma cells, anemia, and lytic lesions, though the PTH should be suppressed in pure myeloma-induced hypercalcemia.
  3. Sarcoidosis (20%): Elevated ACE and calcified LAD suggest this remains a background factor or a co-morbidity contributing to hypercalcemia via calcitriol.
  4. Paraneoplastic Syndrome (5%): PTHrP-mediated, though less likely with a detectable PTH.

Prioritized Tests:
1. Sestamibi Scan or 4D-CT Neck: To localize a parathyroid adenoma/carcinoma.
2. Serum 1,25-dihydroxyvitamin D: To see if sarcoidosis is co-contributing.
3. PTHrP: To rule out concurrent humoral hypercalcemia of malignancy.
4. Repeat Bone Marrow Biopsy/FISH: To further characterize the plasma cell dyscrasia.
5. Cystoscopy: To address the unexplained hematuria.

Attending:

Hello Attending Consultant here.

Top 3 Differential Diagnoses:
1. Sarcoidosis with calcitriol-mediated hypercalcemia (elevated ACE, calcified hilar LAD, low 25-OH D, suppressed PTH, recurrent episodes).
2. IgM kappa plasma cell dyscrasia (MGUS vs smoldering myeloma; 7% kappa-restricted plasma cells, M-spike, osteopenia, calvarial/leg lucencies, anemia).
3. Concurrent primary hyperparathyroidism (inappropriately non-suppressed PTH at 22 pg/mL with Ca 17.1; possible coexistent adenoma).

Suggested improvements (6 points):
- Measure 1,25-(OH)₂D and PTHrP immediately to confirm mechanism.
- Perform 4D-CT neck or sestamibi scan for parathyroid localization.
- Obtain whole-body low-dose CT or PET-CT to characterize lytic lesions and subpleural nodule.
- Repeat bone marrow with flow cytometry, cytogenetics, and MYD88 testing (IgM context).
- Initiate urgent hypercalcemia Rx: IV saline, calcitonin, denosumab (renal-safe); avoid bisphosphonates until Cr improves.
- Proceed with cystoscopy and renal biopsy if no clear cast nephropathy.
- Re-evaluate for neurosarcoid given choreiform movements.

Prioritize reversible hypercalcemia while clarifying overlapping granulomatous and clonal processes.

Expert:

Hello, Expert Clinician here.

Best current unifying diagnosis: likely two coexisting processes, with sarcoidosis/granulomatous disease driving hypercalcemia/AKI and an incidental or low-burden IgM kappa monoclonal gammopathy. The plasma cell findings do not yet establish myeloma.

Why:
- For sarcoid: calcified bilateral hilar/mediastinal LAD, elevated ACE, low 25-OH vitamin D, recurrent hypercalcemia.
- Against pure sarcoid: PTH of 22 pg/mL is inappropriately non-suppressed at Ca 17.1, so granulomatous hypercalcemia alone is unlikely.
- For myeloma: anemia, renal failure, bone lucencies, M-protein.
- Against myeloma: IgM paraprotein is unusual for myeloma; marrow has only 7% plasma cells, below diagnostic threshold unless lesions are unequivocal. Lucencies may be nonspecific/metastatic/osteopenic.

Top differentials:
1. Sarcoidosis + concomitant primary hyperparathyroidism
2. IgM plasma cell neoplasm/lymphoplasmacytic disorder
3. Metastatic malignancy causing bone lesions/hematuria

Key pivot: the non-suppressed PTH despite extreme hypercalcemia—this strongly suggests PTH-dependent contribution.

Most important next move: treat severe hypercalcemia now, and urgently get 1,25-(OH)₂D, PTHrP, parathyroid imaging, and definitive characterization of bone lesions (whole-body low-dose CT/PET-CT).

Teaching pearl: In severe hypercalcemia, a “normal” PTH is abnormal.

Round 4

User: He was treated with aggressive IV fluids, salmon calcitonin, and pamidronate, along with a session of hemodialysis. Calcium improved to 10.1 mg/dL, but renal function remained poor. A subsequent FDG-PET scan showed marked avidity in the mediastinal and hilar lymph nodes. A renal biopsy was performed, which revealed chronic active tubulointerstitial nephritis with poorly formed non-necrotizing granulomas.

Resident:

Hello, Chief Resident here.

The renal biopsy is the "smoking gun," confirming Sarcoidosis as the primary driver of this patient's presentation. The presence of non-necrotizing granulomas and tubulointerstitial nephritis explains the severe AKI and recurrent hypercalcemia (via extra-renal 1-alpha-hydroxylase). The FDG-PET avidity in the mediastinal/hilar nodes confirms active sarcoidosis despite the chronicity suggested by calcifications.

Differential Diagnoses:

  1. Sarcoidosis (85%): Confirmed by renal biopsy and PET-positive lymphadenopathy. Explains hypercalcemia, AKI, and elevated ACE.
  2. Disseminated Tuberculosis (10%): Granulomatous disease can look identical on biopsy; however, the lack of necrosis (caseation) and symmetric hilar involvement favor sarcoid.
  3. Monoclonal Gammopathy of Undetermined Significance (MGUS) (5%): The 7% plasma cells and IgM M-protein are likely an incidental finding or "monoclonal gammopathy of renal significance," but not the cause of the granulomas.

Management & Next Steps:
1. Initiate Corticosteroids: Prednisone is the first-line treatment for sarcoid-related hypercalcemia and interstitial nephritis.
2. 1,25-dihydroxyvitamin D level: To confirm the biochemical mechanism.
3. Parathyroid Imaging (Sestamibi/4D-CT): To investigate the inappropriately non-suppressed PTH (22 pg/mL), which still suggests a concurrent parathyroid adenoma.
4. AFB Staining/Culture: Ensure biopsy tissue is negative for mycobacteria.
5. Cystoscopy: Still required to rule out malignancy given the hematuria.

Attending:

Hello Attending Consultant here.

Top 3 Differential Diagnoses:
1. Pulmonary-renal sarcoidosis (non-caseating granulomas on biopsy, FDG-avid calcified hilar/mediastinal nodes, elevated ACE, calcitriol-mediated hypercalcemia, TIN-induced AKI).
2. Occult IgM-related lymphoproliferative disorder (7% kappa-restricted plasma cells, M-spike, lytic lesions; possible granulomatous reaction).
3. Treated hypercalcemia of malignancy (prior PTHrP or osseous mets; less likely given biopsy).

Suggested improvements (6 points):
- Start prednisone 0.5–1 mg/kg/day for granulomatous TIN and hypercalcemia.
- Measure 1,25-(OH)₂D to confirm extrarenal 1α-hydroxylase activity.
- Perform AFB, fungal, and mycobacterial cultures/PCR on biopsy to exclude infection.
- Obtain neck 4D-CT or sestamibi for concurrent primary hyperparathyroidism (inappropriately detectable PTH).
- Repeat SPEP/UPEP, free light chains, and consider MYD88 testing for IgM clone.
- Proceed with cystoscopy; add low-dose CT chest for nodule surveillance.
- Monitor Ca, Cr, and taper steroids slowly with steroid-sparing agent if relapse occurs.

Prioritize immunosuppression while excluding mimics.

Expert:

Hello, Expert Clinician here.

Best unifying diagnosis: Systemic sarcoidosis with renal sarcoid causing granulomatous tubulointerstitial nephritis and calcitriol-mediated hypercalcemia, leading to severe AKI. This is now tissue-supported.

Top differentials:
1. Tuberculosis/fungal granulomatous nephritis — must still be excluded because biopsy granulomas can overlap; prior positive Mantoux raises this issue. But poorly formed non-necrotizing granulomas, symmetric FDG-avid hilar/mediastinal nodes, elevated ACE, and chronic calcified LAD strongly favor sarcoid.
2. IgM monoclonal gammopathy/lymphoplasmacytic disorder — likely coexisting, not primary driver of renal failure/hypercalcemia.
3. Concurrent primary hyperparathyroidism — still possible because PTH was not fully suppressed.

Key pivot: the renal biopsy. Granulomatous interstitial nephritis plus PET-avid thoracic nodes converts this from suspicion to a near-definitive sarcoid diagnosis.

Most important next move: Start corticosteroids now (eg prednisone), while sending AFB/fungal stains, cultures/PCR on biopsy tissue and reassessing calcium/creatinine response. Also continue workup of the IgM clone and persistent hematuria separately.

Teaching pearl: In sarcoidosis, kidney injury often reflects granulomatous interstitial nephritis, not just hypercalcemia/nephrocalcinosis.

Round 5

User: The final diagnostic procedure was a paratracheal lymph node biopsy. Histopathology showed the node was subtotally replaced by compact, confluent, non-necrotizing granulomas with microfocal necrosis. Stains and cultures for acid-fast bacilli and fungi were negative. The final diagnosis was sarcoidosis (likely with renal and potentially neurological involvement). He was started on oral glucocorticoids, leading to significant improvement and stabilization of renal function (baseline creatinine 1.6 mg/dL) and resolution of choreiform movements.

Resident:

Hello, Chief Resident here.

The final findings confirm Systemic Sarcoidosis with multi-organ involvement, including the lungs, mediastinal lymph nodes, kidneys (granulomatous tubulointerstitial nephritis), and the central nervous system (neurosarcoidosis).

Key Findings & Analysis:
* Renal: Biopsy-proven granulomatous interstitial nephritis explains the severe AKI and recurrent hypercalcemia.
* Neurological: The resolution of choreiform movements with steroids strongly suggests neurosarcoidosis affecting the basal ganglia.
* Biochemical: The "inappropriately normal" PTH (22 pg/mL) likely reflected a blunted response or early recovery, though sarcoidosis was the clear driver of the 17.1 mg/dL peak.
* Hematologic: The IgM kappa component and 7% plasma cells represent a coexisting Monoclonal Gammopathy of Undetermined Significance (MGUS), which requires long-term monitoring but was not the acute driver.

Final Differential Diagnoses:
1. Systemic Sarcoidosis (100%): Confirmed by lymph node and renal biopsies, PET avidity, and dramatic steroid response.

Management:
* Steroid Taper: Gradual reduction of glucocorticoids to prevent relapse of renal and neurosarcoidosis.
* Surveillance: Serial Creatinine, Calcium, and ACE levels.
* Malignancy Screening: Follow-up cystoscopy for hematuria and monitoring of the IgM clone.

Attending:

Hello Attending Consultant here.

Top 3 Differential Diagnoses:
1. Multisystem sarcoidosis (non-necrotizing granulomas on LN + renal biopsy, FDG-avid calcified hilar/mediastinal nodes, elevated ACE, calcitriol hypercalcemia, TIN, steroid-responsive neurosarcoid).
2. IgM lymphoproliferative disorder with granulomatous reaction (kappa-restricted plasma cells, M-spike, lytic lesions).
3. Occult mycobacterial infection (microfocal necrosis, prior PPD; stains/cultures negative).

Suggested improvements (5 points):
- Measure 1,25-(OH)₂D to confirm mechanism and guide steroid dosing.
- Perform full neurosarcoid workup (MRI brain/orbits with contrast, CSF analysis).
- Obtain whole-body low-dose CT or repeat PET for occult malignancy/lytic lesion characterization.
- Monitor IgM clone with serial SPEP/free light chains and consider rituximab if progressive.
- Initiate steroid-sparing agent (methotrexate or infliximab) early to minimize long-term glucocorticoid toxicity in elderly patient.
- Complete urologic evaluation (cystoscopy, upper tract imaging) for recurrent hematuria.
- Track renal recovery with serial eGFR, urine calcium, and ACE levels.

Dramatic steroid response supports sarcoid as primary driver.

Expert:

Hello, Expert Clinician here.

Best unifying diagnosis: Multisystem sarcoidosis with renal sarcoid (granulomatous tubulointerstitial nephritis) causing severe hypercalcemia/AKI, and likely neurosarcoidosis given steroid-responsive chorea.

Why it fits:
- Biopsy-proven non-necrotizing granulomas in kidney and paratracheal node
- FDG-avid bilateral hilar/mediastinal nodes, elevated ACE
- Hypercalcemia with low 25-OH vitamin D, steroid response
- Renal recovery after glucocorticoids supports inflammatory granulomatous TIN

Top differentials and why less likely:
1. TB/fungal infection — microfocal necrosis and prior positive Mantoux raise concern, but AFB/fungal stains and cultures negative, pattern and response favor sarcoid.
2. Plasma cell/IgM clonal disorder — likely coexisting MGUS/low-burden lymphoplasmacytic process; does not explain granulomatous nephritis or steroid-responsive chorea.
3. Primary hyperparathyroidism — “normal” PTH was misleading; overall clinicopathologic picture is sarcoid.

Key pivot: Tissue diagnosis from kidney and lymph node plus dramatic steroid response.

Most important next move: Continue glucocorticoid taper with close monitoring of calcium, creatinine, and symptoms; consider steroid-sparing therapy if relapse/toxicity. Complete separate surveillance for hematuria and the IgM clone.

Teaching pearl: In sarcoidosis, renal failure may come from granulomatous interstitial nephritis, not just hypercalcemia.

Top 15 Takeaways for Clinicians

  1. Stable, coarsely calcified bilateral hilar lymphadenopathy is the hallmark of chronic granulomatous disease. Symmetric nodes unchanged over months point toward sarcoidosis—not lymphoma.
  2. In granulomatous hypercalcemia, PTH is suppressed and 1,25-(OH)₂ vitamin D is elevated. Extrarenal 1-alpha-hydroxylase in activated macrophages drives this biochemical pattern.
  3. A "normal" PTH in severe hypercalcemia is abnormal. At a calcium of 17.1 mg/dL, PTH should be undetectable—a value of 22 pg/mL suggests inappropriate non-suppression or a mixed mechanism.
  4. Renal failure in sarcoidosis is most commonly due to granulomatous interstitial nephritis. The kidney biopsy showing non-necrotizing granulomas with tubulointerstitial nephritis is the tissue diagnosis.
  5. Renal biopsy plus FDG-avid thoracic lymphadenopathy converts suspected sarcoidosis into near-definitive diagnosis. Tissue-proven granulomas plus PET-positive symmetric nodes establish multisystem sarcoidosis.
  6. Always exclude TB and fungal infection before starting corticosteroids for granulomatous disease. Non-necrotizing granulomas alone do not distinguish sarcoid from TB.
  7. Severe hypercalcemia (>14 mg/dL) requires aggressive IV saline, calcitonin, and antiresorptive therapy. Hemodialysis if refractory.
  8. An IgM monoclonal gammopathy with <10% plasma cells is most often MGUS, not myeloma. In this case, 7% kappa-restricted plasma cells and a small M-spike were incidental.
  9. Choreiform movements resolving with corticosteroids suggest neurosarcoidosis of the basal ganglia. Steroid responsiveness is both therapeutic and diagnostic.
  10. FDG-PET can confirm active granulomatous inflammation even when CT shows chronic calcified nodes. PET avidity indicates ongoing metabolic activity and should prompt treatment.
  11. Dramatic steroid response is itself diagnostic for sarcoidosis. The triad of clinical, biochemical, and radiographic improvement completes the picture.
  12. Recurrent hematuria plus flank pain plus hypercalcemia requires evaluation for both sarcoidosis and RCC. Persistent hematuria demands urologic evaluation even after sarcoid is confirmed.
  13. Elevated ACE levels support sarcoidosis but are neither sensitive nor specific. Use it as a supporting clue, not a standalone diagnostic test.
  14. Hypercalcemia of malignancy and granulomatous hypercalcemia are distinguished by PTHrP vs. 1,25-(OH)₂D. Measuring both is essential.
  15. In an elderly patient with CRAB features, never assume myeloma alone when granulomatous clues coexist. Sarcoidosis with secondary MGUS can mimic myeloma exactly.